Supplementary Figure 1 from Aberrant Expression of Mucin Core Proteins and O-Linked Glycans Associated with Progression of Pancreatic Cancer

Authors:
  • NRNeeley Remmers
    Neeley Remmers
  • JAJudy M. Anderson
    Judy M. Anderson
  • ELErin M. Linde
    Erin M. Linde
  • DDDominick J. DiMaio
    Dominick J. DiMaio
  • ALAudrey J. Lazenby
    Audrey J. Lazenby
  • HWHans H. Wandall
    Hans H. Wandall
  • UMUlla Mandel
    Ulla Mandel
  • HCHenrik Clausen
    Henrik Clausen
  • FYFang Yu
    Fang Yu
  • MHMichael A. Hollingsworth
    Michael A. Hollingsworth

Abstract
PDF file - 248K, Supplementary Figure 1. (A) Simplified schematic of mucin type O-glycans analyzed in this report. Mucin-type O-linked glycans are initiated by the addition of an N-acetyl galactose sugar residue (the Tn epitope), which can be extended into the T antigen or core 3 structures, or Tn can be sialylated creating terminal STn that cannot be further extended. T antigen can be extended into core 2 structures that lead to the Lewis Blood Group antigens - LeX, SLeX, SLeC and sialyl Lewis A (the CA19-9 antigen, a widely utilized biomarker of adenocarcinoma progression). B & C - Representative immunohistochemical results for comparison of expression of mucin core proteins, glycans, and glycopeptides taken at 200x magnification. (B) Serial sections of primary tumor from autopsy patient 3 stained for indicated antigens. (C) Serial sections of liver metastasis from autopsy patient 20 for same antigens seen in primary tumor.